Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Translational, interdisciplinary research projects in the field of Personalised Medicine which encourage collaboration between academia, clinical/public health research, SMEs as well as policy makers, regulatory/HTA agencies and patient organisations.
Característiques principals
With its fourth transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between clinical research, computer science/medical informatics and research on ethical, legal and social aspects (ELSA) in the field of PM. This implies a wide range of multidisciplinary activities brought together by different stakeholders from academia, clinical/public health research and private partners such as small and medium-sized enterprises (SMEs), policy makers, regulatory/health technology assessment (HTA) agencies and patients/patient organisations.
The overarching goal is to improve disease prevention and disease management, based on broader and more efficiently characterised and defined patient stratification, diagnostics and tailored treatment/prevention protocols for both patients and individuals at risk of disease. Early involvement of regulatory authorities and close interaction with the different key contributors along the value chain should be included right from the project development phase to bridge the gap between first discoveries or inventions to market access.
Research proposals submitted under this call are expected to demonstrate the applicability of project outcomes to clinical practice and to combine clinical research with data technologies. This could be the development and application of clinical decision support tools by using artificial intelligence (AI) systems approaches, including machine learning technologies. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated. Moreover, proposals must include research on ethical, legal and social aspects.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
Convocatòria (URL)
http://www.erapermed.eu/joint-calls/joint-transnational-call-2021/
Submission of proposals is mandatory on: https://ptoutline.eu/app/erapermed2021
Informació addicional
If you are looking for potential partners, please have a look also at the ICPerMed Partnering Tool: https://partnering.pt-dlr.de/ICPerMed
Requisits
Eligibility Criteria:
  • Only transnational projects shall be funded.
  • Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call. All three legal entities must be independent from each other.
  • At least two partners out of the minimum three eligible project partners of the consortium must be from two different EU Member States or Associated Countries.
  • The project coordinator must be eligible to be funded by his/her national/regional participating funding organisations.
  • The maximum number of partners per project at the pre-proposal stage is six. At the full-proposal stage, the consortium can be increased up to seven partners in total only by inclusion of a partner coming from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited for full- roposal submission.
  • Within one consortium, not more than two partners from the same country participating in the call will be accepted, including those partners with their own funding.. For some funding agencies the maximum number of eligible partners that can be funded in one project is limited to one partner (see also "Guidelines for applicants" regarding individual funding rules).
  • Partners not eligible for funding by one of the organisations participating in this JTC (e.g. from non-funding countries or not fundable according to the national/regional regulations of the participating funding organisations) may participate in projects if they are able to secure their own funding. No more than one partner with its own funding is allowed in consortia with at least three partners eligible for funding.

    Joint research proposals may be submitted by applicants belonging to one of the following categories (according to national/regional regulations of the funding organizations, please see “Guidelines for applicants”):

    A. Academia (research teams working in universities, other higher education institutions) or research institutes;
    B. Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of medical doctors in the research teams is encouraged;
    C. (Industry) Private partners, e.g. SMEs (small and medium-size enterprises).
    Consortia submitting applications to this call are strongly encouraged to include partners from different categories (A, B and C)
    For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members.

    Please contact the Servei de Recerca of you intend to apply for this call, in order to confirm your eligibility and the different funding entities you can apply to.
    • Dotació
    For Spanish participants:
    Between €150,000 to € €250,000 depending on the role and funding entity. Please see the Guidelines for further information.
    Durada
    3 years
    AVÍS IMPORTANT
    The submission of proposals follows a two-stage procedure:
  • Submission deadline for pre-proposals: 4 March 2021 (17:00 CET)
  • Submission deadline for full-proposals: 17 June 2021 (17:00 CEST)

    Spanish partners applying for funding through ISCIII and FCAECC (proposals related to cancer) must submit in addition the form: “Additional application form for Spanish applicants applying for funding from ISCIII/FCAECC”

    • Arxius

    Arxiu
    5_ERA-PerMed_JTC2021_Pre-Proposal_form_Vf.docx
    ERA-PerMed_2021_Call_text_FV_12_12_20.pdf
    ANNEX-3-ERA-PerMed-ISCIII-AECC-FC-JTC2021.docx
    UPDATED-2_ERA-PerMed_JTC2021_Guidelines-FV_18_02_21.pdf